All In Biotech

Drug Trial Radar · NCT03723655

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

A Long-Term Safety Extension Study of Mavacamten (MYK-461) in Adults With Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)

Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 314 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

314

Actual

Start

Sep 27, 2018

Primary completion

Jan 16, 2026

Study completion Jan 16, 2026

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Oct 29, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Approximately 30 sites that enrolled participants in the MAVERICK-HCM (MYK-461-006) study in the United States (US) will initiate this study. Approximately 90 sites that enrolled participants in the EXPLORER-HCM (MYK-461-005) study in the US, Europe, and Israel will initiate this study. Note: Approximately 30 centers overlap between MAVERICK and EXPLORER.

Conditions

  • Hypertrophic Cardiomyopathy
  • Obstructive Hypertrophic Cardiomyopathy
  • Non-obstructive Hypertrophic Cardiomyopathy

Interventions

  • mavacamtenDrug

    mavacamten capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency and severity of treatment-emergent adverse events and serious adverse eventsTime frame: 252 weeks

Locations

68 sites in 13 countries. Site status is shown where the registry gives one.

  • Local Institution - 0045

    Scottsdale, Arizona

  • Local Institution - 0058

    Los Angeles, California

  • Local Institution - 0066

    San Francisco, California

  • Local Institution - 0063

    Stanford, California

  • Local Institution - 0043

    New Haven, Connecticut

  • Local Institution - 0067

    Jacksonville, Florida

  • Local Institution - 0050

    Chicago, Illinois

  • Local Institution - 0070

    Indianapolis, Indiana

  • Local Institution - 0049

    Iowa City, Iowa

  • Local Institution - 0054

    Boston, Massachusetts

  • Local Institution - 0051

    Ann Arbor, Michigan

  • Local Institution - 0074

    Grand Rapids, Michigan

  • Local Institution - 0048

    St Louis, Missouri

  • Local Institution - 0060

    New York, New York

  • Local Institution - 0056

    New York, New York

  • Local Institution - 0071

    Charlotte, North Carolina

  • Local Institution - 0047

    Durham, North Carolina

  • Local Institution - 0052

    Cincinnati, Ohio

  • Local Institution - 0044

    Portland, Oregon

  • Local Institution - 0068

    Bethlehem, Pennsylvania

  • Local Institution - 0046

    Philadelphia, Pennsylvania

  • Local Institution - 0064

    Pittsburgh, Pennsylvania

  • Local Institution - 0073

    Memphis, Tennessee

  • Local Institution - 0061

    Dallas, Texas

  • Local Institution - 0055

    Houston, Texas

  • Local Institution - 0057

    Houston, Texas

  • Local Institution - 0072

    Murray, Utah

  • Local Institution - 0062

    Salt Lake City, Utah

  • Local Institution - 0053

    Charlottesville, Virginia

  • Local Institution - 0059

    Richmond, Virginia

  • Local Institution - 0065

    Seattle, Washington

  • Local Institution - 0002

    Aalst, Belgium

  • Local Institution - 0001

    Brussels, Belgium

  • Local Institution - 0003

    Edegem, Belgium

  • Local Institution - 0010

    Prague, Czechia

  • Local Institution - 0009

    Prague, Czechia

  • Local Institution - 0011

    Aarhus, Denmark

  • Local Institution - 0012

    Frederiksberg, Denmark

  • Local Institution - 0013

    Odense, Denmark

  • Local Institution - 0014

    Nantes, France

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.